Enovix Corp — Director's Dealing 2021

Jul 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Enovix Corp (ENVX)
CIK: 0001828318
Period of Report: 2021-07-14

Reporting Person: RUST HARROLD J (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-14	Common Stock	A	1376031	—	Acquired	1376031	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-14	Stock Option (Right to Buy)	$0.0498	A	24230	Acquired	2027-12-13	Common Stock (24230)	Direct
2021-07-14	Stock Option (Right to Buy)	$9.2626	A	1107677	Acquired	2031-04-19	Common Stock (1107677)	Direct
2021-07-14	Stock Option (Right to Buy)	$9.2626	A	266156	Acquired	2031-04-19	Common Stock (266156)	Direct

Footnotes

F1: Received pursuant to the Agreement and Plan of Merger, dated as of February 22, 2021, by and among Rodgers Silicon Valley Acquisition Corp, a Delaware corporation ("RSVAC"), RSVAC Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of RSVAC ("Merger Sub"), and Enovix Corporation, a Delaware corporation ("Legacy Enovix"), pursuant to which (i) Merger Sub merged with and into Enovix, with Enovix surviving the merger as a wholly owned subsidiary of RSVAC and (ii) RSVAC changed its name to Enovix Corporation.

F2: The shares are held by the Harrold and Margaret Rust Family Trust UTD May 15, 1996, for which the Reporting Person is a trustee.

F3: The shares subject to the option are immediately exercisable and vest in 48 equal monthly installments beginning on the vesting commencement date, September 1, 2017, subject to Reporting Person's continuous service through each such vesting date.

F4: Received in exchange for a stock option to purchase 131,250 shares of Legacy Enovix Common Stock.

F5: The shares subject to the option are immediately exercisable and vest in 60 equal monthly installments beginning on the vesting commencement date, April 18, 2021, subject to Reporting Person's continuous service through each such vesting date.

F6: Received in exchange for a stock option to purchase 6,000,000 shares of Legacy Enovix Common Stock.

F7: The shares subject to the option are immediately exercisable. 1/120th of the shares subject to the option vest monthly over 4 years beginning on the vesting commencement date, April 18, 2021, and 1/20th of the shares subject to the option vest monthly thereafter over the next year, subject to Reporting Person's continuous service through each such vesting date.

F8: Received in exchange for a stock option to purchase 1,441,700 shares of Legacy Enovix Common Stock.